Mammalian-target of rapamycin inhibition with temsirolimus in myelodysplastic syndromes (MDS) patients is associated with considerable toxicity: results of the temsirolimus pilot trial by the German MDS Study Group (D-MDS).
| Image |  |
|---|---|
| Description | scientific article published on 7 October 2016 |
| Author/s |
author: Ina-Maria Klut Claudia Schönefeldt Christiane Jakob Martin Wermke Leopold Hentschel Florian Nolte Ulrich Germing Uwe Platzbecker Martin Bornhäuser Malte von Bonin Gustavo Baretton Gerhard Ehninger |
| Publication date | October 7, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |